Status:
COMPLETED
Effect of Immediate Hemoglobin A1c on Glycemic Control in Children With Type I Diabetes Mellitus
Lead Sponsor:
Boston Children's Hospital
Conditions:
Type 1 Diabetes Mellitus
Glycemic Control
Eligibility:
All Genders
2-18 years
Phase:
PHASE4
Brief Summary
Immediate feedback of hemoglobin A1c (A1c) results to adults with type 1 and 2 diabetes allows more appropriate care decisions at the clinic visit and may improve glycemic control. The investigators' ...
Detailed Description
Because glycosylated hemoglobin (A1c) has been shown to reflect average glycemia over several months and has a strong predictive value for diabetes complications, routine quarterly measurements is a s...
Eligibility Criteria
Inclusion
- Type 1 diabetes mellitus diagnosed at least 2 years prior to enrollment in study
- Less than 18 years of age
Exclusion
- Cystic fibrosis related diabetes
- Type 2 diabetes
- Any other suspected non-type 1 diabetes (e.g., maturity onset diabetes of the young)
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2006
Estimated Enrollment :
234 Patients enrolled
Trial Details
Trial ID
NCT00898534
Start Date
November 1 2003
End Date
January 1 2006
Last Update
May 12 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Boston
Boston, Massachusetts, United States, 02115